Efficacy and Safety of Disitamab Vedotin Plus Pyrotinib or Naratinib in HER2-positive Breast Cancer Patients With Brain Metastasis

Condition:   Breast Cancer Intervention:   Drug: Disitamab Vedotin plus pyrotinib or naratinib Sponsor:   Xi'an International Medical Center Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials